Target intelligence / Profile preview

Probiotic bacterial surface protein

Molecular classification
Bacterial surface protein, Adhesin, S-layer protein, Moonlighting protein
01

Overview

Probiotic bacterial surface proteins (PBSPs) are a diverse group of molecules located on the outer layers of beneficial bacteria, such as Lactobacillus and Bifidobacterium species (Lebeer et al., 2010, Nature Reviews Microbiology). These proteins, including surface layer (S-layer) proteins, adhesins, and moonlighting proteins, play a critical role in the interaction between the probiotic and the host's gastrointestinal environment (Hynönen & Palva, 2013, Reviews in Medical Microbiology). Their primary biological functions include mediating adhesion to the intestinal mucosa, which facilitates colonization and competitive exclusion of pathogens (Sanchez et al., 2008, Applied and Environmental Microbiology). Furthermore, PBSPs are known to interact with host immune cells through pattern recognition receptors like Toll-like receptor 2 (TLR2), thereby modulating immune responses and strengthening the intestinal barrier (Yan & Polk, 2011, Current Opinion in Gastroenterology). While not traditional therapeutic targets for pharmacological inhibition, they are essential components in the development of postbiotics and engineered probiotic delivery systems for treating inflammatory bowel disease and enteric infections (Lebeer et al., 2010).

Other names
S-layer proteinSurface layer proteinBacterial adhesinMoonlighting proteinMucin-binding proteinMUBPili proteinFlagellinSlpMapA
02

Mechanism of action

Probiotic bacterial surface proteins (PBSPs) facilitate competitive exclusion of pathogens by occupying adhesion sites on the intestinal mucosa and modulate host immunity by binding to pattern recognition receptors, such as Toll-like receptor 2 (TLR2), which triggers anti-inflammatory cytokine production and enhances epithelial barrier function (Lebeer et al., 2010; Yan & Polk, 2011).

03

Biological functions

Cell adhesionImmune modulationPathogen exclusionIntestinal barrier enhancementSignal transduction
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeEnteric infectionAllergyAtopic dermatitis
05

Safety considerations

Systemic translocation in immunocompromised individualsHorizontal gene transfer of resistance factorsStrain-specific variability in therapeutic outcomes
06

Interacting drugs

Lactobacillus acidophilus

3 more in the full profile.

07

Biomarkers

Fecal calprotectinSecretory IgA (sIgA)IL-10/IL-12 ratioLactulose/mannitol ratio

Beyond the preview

Go deeper on Probiotic bacterial surface protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probiotic bacterial surface protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call